Bajor A - Search Results

1

Anti-TNF Therapy Response in Patients with Ulcerative Colitis Is Associated with Colonic Antimicrobial Peptide Expression and Microbiota Composition.

Magnusson MK, Strid H, Sapnara M, Lasson A, Bajor A, Ung KA, Öhman L. Magnusson MK, et al. Among authors: bajor a. J Crohns Colitis. 2016 Aug;10(8):943-52. doi: 10.1093/ecco-jcc/jjw051. Epub 2016 Feb 19. J Crohns Colitis. 2016. PMID: 26896085

2

CD25 and TNF receptor II reflect early primary response to infliximab therapy in patients with ulcerative colitis.

Magnusson MK, Dahlén R, Strid H, Isaksson S, Simrén M, Lasson A, Bajor A, Ung KA, Ohman L. Magnusson MK, et al. Among authors: bajor a. United European Gastroenterol J. 2013 Dec;1(6):467-76. doi: 10.1177/2050640613502962. United European Gastroenterol J. 2013. PMID: 24917999 Free PMC article.

3

Response to infliximab therapy in ulcerative colitis is associated with decreased monocyte activation, reduced CCL2 expression and downregulation of Tenascin C.

Magnusson MK, Strid H, Isaksson S, Bajor A, Lasson A, Ung KA, Öhman L. Magnusson MK, et al. Among authors: bajor a. J Crohns Colitis. 2015 Jan;9(1):56-65. doi: 10.1093/ecco-jcc/jju008. Epub 2014 Nov 26. J Crohns Colitis. 2015. PMID: 25518051

4

Global mucosal and serum cytokine profile in patients with ulcerative colitis undergoing anti-TNF therapy.

Dahlén R, Magnusson MK, Bajor A, Lasson A, Ung KA, Strid H, Öhman L. Dahlén R, et al. Among authors: bajor a. Scand J Gastroenterol. 2015;50(9):1118-26. doi: 10.3109/00365521.2015.1031167. Epub 2015 Apr 16. Scand J Gastroenterol. 2015. PMID: 25877762

5

Cultured blood T-cell responses predict anti-TNF therapy response in patients with ulcerative colitis.

Magnusson MK, Strid H, Isaksson S, Bajor A, Lasson A, Ung KA, Öhman L. Magnusson MK, et al. Among authors: bajor a. Aliment Pharmacol Ther. 2015 Jun;41(11):1149-61. doi: 10.1111/apt.13192. Epub 2015 Apr 8. Aliment Pharmacol Ther. 2015. PMID: 25858346 Free article.

6

Increased colonic bile acid exposure: a relevant factor for symptoms and treatment in IBS.

Bajor A, Törnblom H, Rudling M, Ung KA, Simrén M. Bajor A, et al. Gut. 2015 Jan;64(1):84-92. doi: 10.1136/gutjnl-2013-305965. Epub 2014 Apr 12. Gut. 2015. PMID: 24727487

7

Normal or increased bile acid uptake in isolated mucosa from patients with bile acid malabsorption.

Bajor A, Kilander A, Fae A, Gälman C, Jonsson O, Ohman L, Rudling M, Sjövall H, Stotzer PO, Ung KA. Bajor A, et al. Eur J Gastroenterol Hepatol. 2006 Apr;18(4):397-403. doi: 10.1097/00042737-200604000-00013. Eur J Gastroenterol Hepatol. 2006. PMID: 16538111

8

Effects of conventional and a novel colonic-release bile acid sequestrant, A3384, on fibroblast growth factor 19 and bile acid metabolism in healthy volunteers and patients with bile acid diarrhoea.

Appleby RN, Bajor A, Gillberg PG, Graffner H, Simrén M, Ung KA, Walters J. Appleby RN, et al. Among authors: bajor a. United European Gastroenterol J. 2017 Apr;5(3):380-388. doi: 10.1177/2050640616662432. Epub 2016 Jul 26. United European Gastroenterol J. 2017. PMID: 28507750 Free PMC article.

9

Authors' response: bile acids are important in the pathophysiology of IBS.

Bajor A, Törnblom H, Rudling M, Ung KA, Simrén M. Bajor A, et al. Gut. 2015 May;64(5):851-2. doi: 10.1136/gutjnl-2014-308037. Epub 2014 Jul 23. Gut. 2015. PMID: 25056657 No abstract available.

10

Physical activity improves symptoms in irritable bowel syndrome: a randomized controlled trial.

Johannesson E, Simrén M, Strid H, Bajor A, Sadik R. Johannesson E, et al. Among authors: bajor a. Am J Gastroenterol. 2011 May;106(5):915-22. doi: 10.1038/ajg.2010.480. Epub 2011 Jan 4. Am J Gastroenterol. 2011. PMID: 21206488 Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

46 results

Search Page